Application 090644
- Type
- ANDA
- Sponsor
- TEVA PARENTERAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GEMCITABINE | GEMCITABINE | INJECTABLE; INJECTION | 2G | No | No |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AVGEMSI | GEMCITABINE | Avyxa Pharma, LLC | e11eeff7-bcaf-4bf1-8da8-88138e01af84 | 2026-07-27 | Warnings, Adverse reactions | GEMCITABINE |
| Gemcitabine | GEMCITABINE | Hospira, Inc. | dc02a23b-3ff9-4441-aa91-8e9e629a7315 | 2026-04-27 | Warnings, Adverse reactions | Gemcitabine GEMCITABINE |
| Gemcitabine | GEMCITABINE | Hospira, Inc. | e18ed1cb-7dd0-4001-bfda-17d1f4587fb8 | 2026-04-27 | Warnings, Adverse reactions | Gemcitabine GEMCITABINE |
| Gemcitabine | GEMCITABINE | Hikma Pharmaceuticals USA Inc. | d80176fe-3e8b-48be-87c2-9c603013b3fa | 2025-10-24 | Warnings, Adverse reactions | Gemcitabine GEMCITABINE |
| Gemcitabine | GEMCITABINE HYDROCHLORIDE | Meitheal Pharmaceuticals Inc. | c0b1b715-9ff8-43ca-9e49-465f1f380084 | 2025-07-23 | Warnings, Adverse reactions | Gemcitabine |
| GEMCITABINE | GEMCITABINE HYDROCHLORIDE | NorthStar Rx LLC | 5af49a48-f1c0-467d-b5da-ac9f1ae8e34c | 2025-02-03 | Warnings, Adverse reactions | GEMCITABINE |
| Gemcitabine | GEMCITABINE | Sagent Pharmaceuticals | 22af3507-4b4f-4cad-9d61-89ffc4aabbc7 | 2025-02-03 | Warnings, Adverse reactions | Gemcitabine GEMCITABINE |
| GEMCITABINE | GEMCITABINE HYDROCHLORIDE | Meitheal Pharmaceuticals Inc. | a5949d02-29eb-4626-ad35-b7614bb0fa95 | 2025-01-29 | Warnings, Adverse reactions | GEMCITABINE |
| Gemcitabine | GEMCITABINE HYDROCHLORIDE | Mylan Institutional LLC | 06dd9d40-74fc-4409-93b1-a46be7126331 | 2024-11-11 | Warnings, Adverse reactions | Gemcitabine |
| GEMCITABINE | GEMCITABINE | Fresenius Kabi USA, LLC | c550dd16-a5e8-44be-87f2-210c15bbb513 | 2024-10-14 | Warnings, Adverse reactions | GEMCITABINE GEMCITABINE |
| gemcitabine | GEMCITABINE | Dr. Reddy's Laboratories Limited | eafcebc8-ddef-bb6b-fd0a-9d8b9962cdc4 | 2024-09-09 | Warnings, Adverse reactions | gemcitabine GEMCITABINE |
| gemcitabine | GEMCITABINE HYDROCHLORIDE | Sagent Pharmaceuticals | 44bcc16c-341d-49e8-a1c6-95d084667aca | 2024-09-06 | Warnings, Adverse reactions | gemcitabine |
| Gemcitabine | GEMCITABINE | Hospira, Inc. | d16907e7-a8c8-4039-ace4-cf4e24ba68c0 | 2024-08-16 | Warnings, Adverse reactions | Gemcitabine GEMCITABINE |
| GEMCITABINE | GEMCITABINE | Hospira, Inc. | a625c92b-c569-4b98-8d2e-2b3f5e12b34f | 2024-08-16 | Warnings, Adverse reactions | GEMCITABINE GEMCITABINE |
| Gemcitabine | GEMCITABINE HYDROCHLORIDE | Meitheal Pharmaceuticals Inc. | 73ae04d8-38f9-4d3d-b0c2-71d22af1fc86 | 2024-08-05 | Warnings, Adverse reactions | Gemcitabine |
| GEMCITABINE | GEMCITABINE | BluePoint Laboratories | 4031017d-d768-46de-8081-476bcb883f5e | 2023-09-11 | Warnings, Adverse reactions | GEMCITABINE GEMCITABINE |
| GEMCITABINE | GEMCITABINE | Fresenius Kabi USA, LLC | d1f3951c-d13f-4662-ad4b-ecfc07f59104 | 2021-01-20 | Warnings, Adverse reactions | GEMCITABINE GEMCITABINE |